![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Sheba Medical Center |
Information provided by: | Sheba Medical Center |
ClinicalTrials.gov Identifier: | NCT00339001 |
To evaluate the possibility that erythropoietin with early iron supplementation may induce retinopathy of prematurity or worsen this disease. In addition risk factors for the development of ROP will be checked.
Condition | Intervention |
Retinopathy of Prematurity |
Drug: erythropoietin and early iron supplements |
MedlinePlus related topics: | Dietary Supplements Retinal Disorders |
ChemIDplus related topics: | Epoetin alfa Erythropoietin Ferrous sulfate |
Study Type: | Observational |
Study Design: | Screening, Longitudinal, Defined Population, Retrospective Study |
Official Title: | The Possible Influence of Erythropoietin and Early Iron Supplements on the Prevalence and Severity of Retinopathy of Prematurity and Other Short Term Outcome of Prematurity |
Ages Eligible for Study: | up to 3 Months |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Jacob Kuint, MD | 972-3-5303030 ext 2227 | kuint-j@sheba.health.gov.il |
Contact: Irit Eisen, MD | 972-3-5303030 ext 2227 |
Israel | |||||
Neonatal Department, Sheba Medical Center | Recruiting | ||||
Ramat-Gan, Israel, 52621 | |||||
Contact: Jacob Kuint, MD 972-3-5303030 ext 2227 kuint-j@sheba.health.gov.il | |||||
Contact: Irit Eisen, MD 972-3-5303030 ext 2227 | |||||
Principal Investigator: Irit Eisen, MD | |||||
Sub-Investigator: Robi Chaviv, med. student |
Sheba Medical Center |
Principal Investigator: | Jacob Kuint, MD | Sheba Medical Center |
Study ID Numbers: | SHEBA-06-4128-JK-CTIL |
First Received: | June 19, 2006 |
Last Updated: | June 19, 2006 |
ClinicalTrials.gov Identifier: | NCT00339001 |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
|
|
|
|
|
![]() |